A Pilot Study of the Efficacy of Alli in the Management of Pre-operative Weight Loss Required for Bariatric Surgery.

Albany College of Pharmacy and Health Sciences19 enrolled

Overview

The primary goal of the study is to determine if orlistat 60mg (Alli) is effective in helping patients achieve a required 10% weight loss goal prior to bariatric surgery. The medication will be added to the usual standard of care which includes education regarding diet and exercise and monthly meetings with a registered dietician.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Obesity

Interventions

OrlistatDRUG

60mg capsule three times a day for up to 6 months

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * adult patients preparing for gastric bypass surgery Exclusion Criteria: * pregnancy

Locations (1)

Albany College of Pharmacy and Health Sciences

Albany, New York, United States

Outcomes

Primary Outcomes

Weight Loss

Weight loss acheived during time on study up to 6 months.

Time frame: 6 months

Secondary Outcomes

Patient Satisfaction

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.